Antibody-drug Conjugate Information
General Information of This Antibody-drug Conjugate (ADC)
| ADC ID |
DRG0GBVZU
|
|||||
|---|---|---|---|---|---|---|
| ADC Name |
FGFR2b-1-AL1- LP32
|
|||||
| Synonyms |
FGFR2b-1-AL1- LP32
Click to Show/Hide
|
|||||
| Organization |
Regeneron Pharmaceuticals, Inc.
|
|||||
| Drug Status |
Investigative
|
|||||
| Drug-to-Antibody Ratio |
7.4
|
|||||
| Structure |
|
|||||
| Antibody Name |
undisclosed
|
|||||
| Antigen Name |
Fibroblast growth factor receptor 2 (FGFR2)
|
Antigen Info | ||||
| Payload Name |
Undisclosed
|
|||||
| Therapeutic Target |
Stimulator of interferon genes protein (STING1)
|
Target Info | ||||
| Linker Name |
Anti-Her2-AL1- LP32 linker
|
Linker Info | ||||
| Conjugate Type |
Random conjugation through nucleophilic lysines
|
|||||
| Combination Type |
LP32
|
|||||